Alerts will be sent to your verified email
Verify EmailSAKAR
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Sakar Healthcare, an Indian pharmaceutical company, manufactures and markets a wide range of pharmaceutical formulations for domestic and international markets. It also provides contract manufacturing services for pharmaceutical companies in India.
Sakar Healthcare major competitors are Gufic Biosciences, Caplin Point Lab, Fredun Pharma, Ind-Swift Lab., Lincoln Pharma, Wanbury, Anuh Pharma.
Market Cap of Sakar Healthcare is ₹852 Crs.
While the median market cap of its peers are ₹885 Crs.
Sakar Healthcare seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | Sep | ||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|